Advertisements

Amiodarone Hcl

Quick links to important sections

Amiodarone Hcl

Selected form

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Amiodarone Hcl

Amiodarone Hydrochloride is a potent, synthetic organic compound primarily used to stabilize the heart's electrical system. It is clinically recognized for its essential role in managing serious cardiac rhythm issues.

Property Description
Active ingredient Amiodarone Hydrochloride
Forms Tablet (Oral), Solution (Intravenous injection)
Pharmacological class Class III Antiarrhythmic Agent
Common use (General) Stabilizing abnormal heart rhythms (Cardiac dysrhythmias)
Origin Synthetic, Iodine-rich benzofuran derivative

What Type of Medicine is Amiodarone Hydrochloride?

Amiodarone Hydrochloride is formally classified as an Antiarrhythmic Agent, serving to stabilize the heart's electrical activity. It falls predominantly into Class III of the Vaughan Williams Classification system, distinguishing it as a key tool for managing serious cardiac dysrhythmias and abnormal heart rhythms. This classification is significant because it indicates the drug's primary action is to increase the amount of time the heart's electrical system needs to recover between beats, known as prolonging the refractory period.

Unlike many other antiarrhythmic drugs that are selective for a single electrical pathway, Amiodarone has a unique profile; it is considered a multichannel blocker as it exhibits characteristics spanning all four antiarrhythmic classes by affecting potassium, sodium, and calcium channels. This broad-spectrum action is a defining, differentiating factor from most single-class rhythm stabilizers.


Composition, Chemical Origin, and Forms

The medicine's sole active ingredient is Amiodarone Hydrochloride, a unique, synthetic molecule characterized chemically as an iodine-rich benzofuran derivative. The presence of iodine significantly influences the drug's persistence in the body, contributing to its exceptionally long half-life.

As a single-ingredient product, Amiodarone is prepared for clinical use in two main dosage forms: an oral tablet for sustained, long-term treatment, and an intravenous solution (injection) primarily used in hospital settings for rapid control of severe rhythm disturbances. The availability of these two forms ensures flexibility in medical use for patients requiring stabilization of tachyarrhythmias.

Advertisements

What side effects are possible with Amiodarone Hcl?

Possible Side Effects and Safety Information

Amiodarone Hcl's official safety profile highlights the potential for serious toxicity in several organ systems. Regulatory documentation specifies the risk of fatal pulmonary toxicity (including fibrosis and Acute Respiratory Distress Syndrome) and fatal hepatic injury (liver failure). Additionally, the drug frequently causes abnormalities in the thyroid (both hypo- and hyperthyroidism), which can sometimes be fatal. Given these serious risks, the medicine is generally reserved for use in life-threatening arrhythmias refractory to other treatments.


Frequency-Classified Adverse Reactions

Classification Examples of Reactions
Very Common Corneal microdeposits, nausea, vomiting
Common Hypothyroidism or hyperthyroidism, photosensitivity, tremor, abnormal liver function tests, nonspecific hepatic disorders, pulmonary inflammation or fibrosis, congestive heart failure.
Uncommon Blue skin discoloration, conduction abnormalities, hypotension.
Rare/Very Rare Optic neuropathy/neuritis (potential for blindness), severe hepatic injury, myxedema coma, proarrhythmia (worsening of arrhythmia).

Safety Considerations and Restrictions

Adverse effects may persist for several weeks to months after discontinuing the medicine due to its exceptionally long half-life. Monitoring of liver function, thyroid function, and pulmonary status is required during treatment. The medicine is contraindicated in patients with cardiogenic shock, severe sinus node dysfunction, and second- or third-degree AV block leading to syncope without a functioning pacemaker, as stated in official labeling. Use during pregnancy may cause fetal harm, and breastfeeding is not recommended.

Advertisements

Overdose and Emergency Response

Amiodarone Hcl Overdose and When to Seek Help

Overdose with Amiodarone Hydrochloride, particularly massive acute ingestion, carries the potential for a fatal outcome, according to official government prescribing information. Consequently, an overdose requires immediate medical attention and is considered a medical emergency.

Officially Documented Manifestations and Risks

Regulatory agencies document specific clinical signs and severe outcomes associated with an overdose. These may include profound cardiovascular instability:

  • Cardiovascular Effects: Hypotension (low blood pressure), Bradycardia (slow heart rate), Atrioventricular (AV) block, Shock, and Circulatory Collapse.
  • Severe Outcomes: Risk of Asystole, Cardiac Arrest, and liver toxicity. High-rate intravenous exposure has also been associated with acute renal failure and hepatic coma.

Required Emergency Actions

Immediate supportive treatment must be initiated following a suspected overdose. Patients are directed to seek medical advice urgently if they experience symptoms of bradycardia or heart block. Due to the drug's properties, there is no specific antidote documented in official labeling, and the substance is not removable by dialysis. Management focuses on supportive measures such as administering activated charcoal, performing gastric lavage, and using temporary pacing for severe heart block. Close clinical monitoring, including regular liver function checks, is mandatory.

Advertisements

Therapeutic Uses of Amiodarone Hcl

Quick Facts: Uses of Amiodarone Hcl

  • May support the management of life-threatening recurrent ventricular fibrillation.
  • May support the management of life-threatening recurrent hemodynamically unstable ventricular tachycardia.
  • Is an option for patients who have not responded to, or cannot tolerate, other approved therapeutic agents for these conditions.

What Amiodarone Hcl Treats: Main Uses and Benefits

Amiodarone Hcl is a medication indicated for the management of certain serious cardiac rhythm disorders. It is considered an option for adult patients experiencing life-threatening recurrent ventricular fibrillation or life-threatening recurrent hemodynamically unstable ventricular tachycardia. These are serious disturbances in the heart's electrical activity that originate in the lower chambers.

This therapy is generally reserved for use when patients have not had a satisfactory response to, or are intolerant of, other antiarrhythmic agents considered for these conditions. The medication may assist in restoring and maintaining a more regulated heart rhythm. The approved uses are strictly defined due to the nature of the condition and the medication's profile.

It is important to note that this compound may also be considered for use in managing other supraventricular tachyarrhythmias (abnormal heart rhythms originating above the ventricles) outside of its formally approved indications, as determined by a healthcare provider based on clinical need and individual patient profile.

Advertisements

Eligibility and Restrictions for Use

Amiodarone HCl is subject to strict eligibility rules based on regulatory standards, primarily concerning severe cardiac conditions and hypersensitivity.

Contraindicated Populations

Use is prohibited for patients with a known hypersensitivity to amiodarone, iodine, or any component of the formulation. It is also contraindicated in individuals with underlying severe heart rhythm problems, including cardiogenic shock, marked sinus bradycardia, or second-/third-degree AV block who do not have a functioning pacemaker.

Specific Use Restrictions

Population / Condition Regulatory Status
Pregnancy Category D (Conditional use; risk to fetus must be justified by maternal benefit).
Lactation Contraindicated; breastfeeding should be discontinued.
Pediatric Patients Safety and efficacy have not been established.
Thyroid Dysfunction Contraindicated for patients with evidence or history of thyroid dysfunction.

Older adults are generally eligible for treatment, though regulatory documents recommend closer clinical monitoring due to the higher likelihood of age-related organ dysfunction. Patients with severe hepatic or renal impairment also require prudence and monitoring.

Advertisements

What should I know about interactions with other medicines?

Official Regulatory Interaction Profile

Amiodarone Hydrochloride interacts significantly with numerous other medicinal products primarily due to its effects on metabolic enzymes and transporters, as documented in official government labeling.

Key Interaction Classifications

Classification Regulatory Status
Radioactive Iodine Therapy Contraindicated (interference with uptake)
Sofosbuvir-Containing Regimens Not Recommended (risk of symptomatic bradycardia)

Pharmacokinetic and Pharmacodynamic Interactions

Regulatory documents identify Amiodarone and its active metabolite as inhibitors of the P-glycoprotein (P-gp) transporter and multiple Cytochrome P450 (CYP) enzymes, including CYP2C9, CYP2D6, and CYP3A4. This inhibition formally increases the plasma concentration (exposure) of co-administered medicines that are substrates for these systems.

  • Exposure Increase: The exposure of Warfarin (a CYP2C9 substrate) and Digoxin (a P-gp substrate) is documented to increase, requiring procedural constraints. Due to CYP3A4 inhibition, a dose limitation is formally required for certain Statins (e.g., Simvastatin must be limited to 20 mg daily) during co-administration.
  • Additive Risk: Co-administration with other medicines that also prolong the cardiac QT interval is formally associated with an increased pharmacodynamic risk.
  • Dietary Restriction: The consumption of Grapefruit Juice must be avoided as it is documented to increase Amiodarone exposure.

Crucially, due to the drug’s exceptionally long half-life, the potential for these officially documented drug interactions is noted to persist for several weeks or months following discontinuation of the medication.

Advertisements

Mechanism of Action

The mechanism of action for Amiodarone Hydrochloride involves simultaneous modulation across several key electrophysiological and metabolic pathways.

Dual-Spectrum Electrical Channel Blockade

Amiodarone functions as a multi-channel blocker primarily by blocking voltage-gated potassium channels (I Kr current), which significantly slows the final phase of electrical recovery (repolarization). This mechanism, combined with modulation of sodium (I Na) and L-type calcium (I Ca, L) channels, increases the Effective Refractory Period (ERP) of cardiac cells. This results in the tissue requiring a longer period before it can be re-excited, thereby interrupting and suppressing the formation of re-entrant electrical circuits.

Sympathetic and Conduction Regulation

The drug also acts as a non-competitive antagonist on mathbfalpha- and mathbfbeta-adrenergic receptors, dampening signals from the sympathetic nervous system. This sympatholytic action reduces the heart's intrinsic firing rate (automaticity) and slows conduction velocity through the AV node. This mechanism reduces the heart's responsiveness to sympathetic stimulation, which results in decreased automaticity and excitability of cardiac tissue.

Unique Metabolic Pathway Modulation

Amiodarone interferes with systemic physiology by inhibiting the enzyme 5^prime-deiodinase, which converts less active T4 into the potent T3 thyroid hormone. This metabolic effect, along with peripheral alpha-blockade, leads to vasodilation and a reduction in myocardial oxygen consumption, which influences electrophysiological functions.

Advertisements

Dosage and Administration Information

Administration Routes and Dosage Forms

Amiodarone Hydrochloride is administered as oral tablets for chronic management and as a solution for intravenous (IV) infusion for acute stabilization. The IV solution must be diluted exclusively in 5% Dextrose in Water (D5W) prior to use.


Standard Dosing Regimens and Schedule

Oral administration follows a phase-based schedule. Therapy begins with a high loading dose, ranging from 800 mg to 1600 mg daily, administered for one to three weeks. The dose is subsequently reduced through an intermediate phase to a final maintenance dose, typically 400 mg daily. Oral doses must be taken consistently with respect to meals to ensure reliable absorption, and high daily doses are generally divided.

The IV regimen is reserved for acute, life-threatening episodes and employs a multi-phase continuous infusion. This schedule delivers an approximate total dose of 1000 mg over the first 24 hours, followed by a continuous, reduced maintenance infusion rate thereafter. IV delivery requires administration via a volumetric infusion pump and should utilize a central venous catheter for higher concentrations.


Population and Procedural Constraints

The safety and effectiveness of the medicine have not been established for pediatric patients. No mandatory dose adjustment is defined for patients with renal or hepatic impairment. IV infusions are used for short-term stabilization (e.g., 48 to 96 hours), while the oral tablet is intended for long-term maintenance after the acute phase.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Amiodarone HCl


Evidence for Life-Threatening Ventricular Arrhythmias

Amiodarone HCl was the subject of research exploring its use in two serious heart rhythm problems: life-threatening recurrent Ventricular Fibrillation (VF) and unstable Ventricular Tachycardia (VT). Research was conducted during periods of increased symptom activity relevant to these conditions.

The research base includes Randomized Controlled Trials (RCTs) conducted in emergency and critical care settings. These trials research examined whether Return of Spontaneous Circulation (ROSC) was observed after administration. Studies also monitored longer-term outcomes like survival to hospital admission and examined patterns related to the frequency of recurrent VF/VT episodes in patients with structural heart disease.


Supportive Research for Atrial and Supraventricular Arrhythmias

Research has also evaluated Amiodarone HCl in numerous meta-analyses and comparative studies to understand its place in managing other common abnormal heart rhythms, such as Atrial Fibrillation (AF) and other Supraventricular Tachyarrhythmias (SVT).

These studies research examined outcomes such as conversion to sinus rhythm and the subsequent outcomes related to the rhythm observed after a patient experienced an AF episode. Researchers also monitored larger systemic outcomes related to total mortality, particularly in specific patient groups, such as those with underlying Chronic Heart Failure.


Research Gaps and Areas of Uncertainty

The body of research for Amiodarone HCl evidence highlights what is known — and what is still uncertain. While studies describe patterns related to acute stabilization (ROSC), comparative evidence is lacking regarding the long-term impact on overall patient survival and quality of life compared to other treatments or devices, like implantable defibrillators. The follow-up durations were limited in many key studies. Research is ongoing to better understand its long-term profile and further research comparing its findings against other available evidence for rhythm control.

Key Studies & References

  1. Label: AMIODARONE HYDROCHLORIDE tablet - DailyMed (Official FDA Labeling Summary)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amiodarone Hcl (FAQ)

Q: Is Amiodarone Hcl considered a type of beta-blocker?

A: Amiodarone is primarily classified by regulatory documents as a Class III antiarrhythmic agent, meaning its main action is to prolong the heart's electrical recovery time. However, official product information notes that it also exhibits noncompetitive alpha- and beta-adrenergic inhibitory activity, which gives it characteristics similar to Class II drugs (beta-blockers).

Q: Are there any long-term health concerns that have been described with Amiodarone Hcl use?

A: Yes, official regulatory labeling carries warnings about the potential for serious and sometimes fatal toxicities associated with the drug's use. These long-term concerns primarily involve damage to the lungs, liver, and thyroid gland. Official labeling notes that monitoring of these organs is required throughout treatment.

Q: Does Amiodarone Hcl cause sun sensitivity, and how serious is it?

A: Official information indicates that Amiodarone is known to cause photosensitivity (increased skin sensitivity to sunlight). This is listed as a potential risk. Official patient information often includes warnings about sun exposure and suggests protective measures, such as the use of sun cream and protective clothing, to manage this common risk.

Q: Can Amiodarone Hcl affect the results of an EKG or other heart monitoring?

A: Yes, this drug is expected to affect heart monitoring results because its purpose is to change the heart's electrical activity. Its pharmacological action often includes a decreased sinus rate and the prolongation of intervals on an electrocardiogram (EKG), such as the QT interval.

Q: What kind of monitoring is typically required when first starting Amiodarone Hcl?

A: Regulatory documents note that hospitalization is often necessary during the initiation of the oral loading dose. Furthermore, regulatory bodies require baseline testing before treatment begins, including a chest X-ray, pulmonary function tests, and thyroid function tests.

Q: What are the general patient expectations regarding continued use of Amiodarone Hcl?

A: The drug is intended for use in patients with life-threatening arrhythmias. Due to the risk of toxicity, official guidelines state that treatment requires close, regular clinical supervision and continued monitoring of organ function throughout the entire course of therapy.

Q: Can Amiodarone Hcl cause digestive issues, like nausea or constipation?

A: Yes, according to official drug safety information, gastrointestinal symptoms are common adverse reactions. These issues include nausea, vomiting, anorexia (loss of appetite), and constipation.

Q: Why is Amiodarone Hcl sometimes mentioned alongside a Black Box Warning?

A: The FDA Prescribing Information carries a Black Box Warning (the most serious type of warning) because the drug's use is accompanied by substantial, sometimes fatal, toxicities. These serious risks primarily involve pulmonary (lung) toxicity and severe liver injury.

Q: Is Amiodarone Hcl used to prevent future episodes of arrhythmia?

A: The drug is officially indicated for the treatment of recurrent, life-threatening ventricular arrhythmias. This use means that it is used to suppress the reoccurrence of these dangerous irregular heart rhythms after they have been initially treated.

Q: How long are the half-life and elimination process of Amiodarone Hcl?

A: Amiodarone has an exceptionally long and highly variable terminal elimination half-life. Official clinical pharmacology documents state the mean half-life is approximately 53 to 58 days, meaning the drug and its effects can persist in the body for many weeks or months after discontinuation.

Q: Is Amiodarone Hcl effective for all types of irregular heartbeats?

A: No, official regulatory indications are limited to treating recurrent, life-threatening ventricular fibrillation and hemodynamically unstable ventricular tachycardia. It is not approved for all types of irregular heartbeats, especially less severe forms.

Q: What is meant by the phrase 'loading dose' for Amiodarone Hcl?

A: A loading dose refers to a higher initial dose given to a patient over a period of time. This is necessary due to the drug's slow absorption and long half-life, allowing it to rapidly accumulate in the body tissues to achieve effective therapeutic concentrations sooner.

Q: How long does it usually take to notice the effects of Amiodarone Hcl?

A: Even with the use of a loading dose, the full clinical effects on abnormal heart rhythms are typically not seen before 2 to 3 days and often require 1 to 3 weeks of oral administration. Effects are not immediate.

Q: If I miss a dose of Amiodarone Hcl, what is the general guidance?

A: According to patient information from authoritative sources, if a dose is missed, the general instruction is to skip that missed dose entirely. The recommended procedure is to continue with the regular dosing schedule and avoid taking a double dose to compensate.

Q: Are there any common over-the-counter medicines or supplements known to interact with Amiodarone Hcl?

A: The official label warns of interactions with numerous substances. For example, the herbal supplement St. John's wort is specifically noted for a potential interaction that could decrease the effectiveness of amiodarone.

Q: Is it common for people to feel fatigued when starting Amiodarone Hcl?

A: Fatigue is a non-specific symptom that is sometimes reported. Official guidance suggests that such symptoms, as they may be associated with thyroid side effects or other complications, should be reported to a healthcare provider for evaluation.

Q: What is the reason Amiodarone Hcl can affect the lungs?

A: Pulmonary toxicity is a serious, potential side effect of the drug. According to the product label, this toxicity may result from either a direct toxic effect on the lung tissue or an immune/hypersensitivity reaction.

Q: How often do people need to adjust their dose of Amiodarone Hcl?

A: Due to the drug's variable absorption and slow elimination, maintenance dosing is often challenging. It is not uncommon for a healthcare professional to need to reduce the dose or temporarily stop the drug because of adverse effects.

Q: Why do some people experience blue or grayish skin discoloration with Amiodarone Hcl?

A: Blue-gray skin discoloration (pigmentation) is a known, though uncommon, adverse effect. Official adverse reaction lists state that this can occur after prolonged exposure to the drug.

Q: What is the term for the accumulation of Amiodarone Hcl in body tissues?

A: Amiodarone has a large volume of distribution, which means it quickly leaves the bloodstream and is known to accumulate extensively in many body tissues, including the liver, lungs, and fat. This tissue saturation is the reason for its extremely long half-life.

Q: What happens if Amiodarone Hcl is taken with certain antifungals or antibiotics?

A: Amiodarone is known to interact with certain other medications. The label notes specific drug interactions, including with some antifungals (like azoles) and antibiotics (like macrolides or fluoroquinolones), which can increase the risk of serious side effects, including dangerous changes in heart rhythm.

Q: Can Amiodarone Hcl affect male or female fertility?

A: The regulatory classification for the chemical substance, which relates to its intrinsic properties, states that it is suspected of damaging fertility or the unborn child.

Q: Are there dietary restrictions besides grapefruit when taking Amiodarone Hcl?

A: The only widely noted and consistent dietary restriction in the patient information from authoritative regulatory sources is the consumption of grapefruit juice. Official patient information requires that grapefruit juice be avoided completely due to the potential for interaction.

Advertisements

How should Amiodarone Hcl be stored and disposed of?

Storage and Disposal Requirements for Amiodarone HCl

Storage and handling instructions for Amiodarone Hydrochloride differ slightly between the oral tablet and the injectable solution, and must strictly follow regulatory guidance to ensure product stability.


Storage Conditions

Formulation Temperature Requirement Environmental Protection
Oral Tablet Controlled Room Temperature (20 C–25 C) Protect from excessive moisture and keep in the original container
Injection Store at 25 C (Excursions 15 C–30 C) Protect from light and do not freeze; store in the original container

All Amiodarone HCl must be stored out of the reach of children. Low temperatures for the injection may cause precipitation, and the solution should be visually inspected for clarity prior to use.


Disposal

Unused or expired product must be disposed of according to local regulations. It is strictly prohibited to dispose of the medicine via wastewater or routine household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amiodarone Hcl found in:

A-Z Index: